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in Italy and Spain (1,9). In southern 
European countries, TOSV is mostly 
transmitted by P. perniciosus and P. 
perfiliewi sandflies (1,6,9), whereas 
P. perniciosus, P. longicuspis, and 
P. perfiliewi are the most abundant 
sandfly species in northern Tunisia. 
It is therefore probable that TOSV is 
transmitted by sandfly species of the 
subgenus Larroussius.
We found that 2 phleboviruses 
belonging to the Sandfly fever Naples 
virus species, TOSV and Punique 
virus, are cocirculating in northern 
Tunisia. This finding calls for further 
investigation of these viruses’ 
potential effect on human health in 
this area.
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Seroprevalence  
of Dengue in  
American Samoa, 
2010
To the Editor: Since the 1970s, 
regular dengue epidemics have 
caused considerable illness in the Pa-
cific region (1). In 2009, an epidemic 
year, the incidence of reported clini-
cal dengue cases in American Samoa 
reached 644 cases/100,000 popula-
tion; in 2010, incidence decreased 
to 77 cases/100,000 population (2). 
Dengue surveillance in American Sa-
moa is being developed, but the ef-
fects of this disease are unknown.
In 2010, blood samples were col-
lected in American Samoa primar-
ily for a leptospirosis seroprevalence 
study. Samples were also tested for 
IgG antibodies against dengue vi-
rus, and a seroprevalence of 95.6% 
was observed. We report this finding 
and advocate improved surveillance 
and integrated control programs to 
limit dengue transmission in Ameri-
can Samoa.
A cross-sectional seroprevalence 
study was conducted during May–
July 2010 with the primary aims of 
identifying risk factors for human 
leptospirosis and providing an evi-
dence base to direct public health in-
terventions in American Samoa (3,4). 
During the study, investigators en-
countered community concern about 
dengue and were asked by health 
authorities to use the remaining col-
lected serum for a dengue serop-
revalence study. Amendments to the 
original human research ethics ap-
plications submitted to the American 
Samoa Institutional Review Board 
and the University of Queensland 
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Medical Research Ethics Committee 
(2010000114) were approved.
From the general population of 
the islands of Tutuila, Aunu’u, and 
Manu’a, 807 adults were recruited. 
Households were selected from Tu-
tuila and Aunu’u Islands by using a 
spatial sampling design to facilitate 
geospatial analysis (4). One adult 
from each household was asked to 
volunteer for the study. The small 
size of villages on the Manu’a Is-
lands meant that spatial sampling 
was not possible; thus, a convenience 
sample of volunteers was recruited. 
A 5-mL blood sample was collected 
from each participant, information 
on demographics and risk exposures 
was obtained by using a standardized 
questionnaire, and each participant’s 
primary place of residence was geo-
referenced.
In October 2011, serum samples 
from 794 participants 18–87 years 
of age (median age 39.5 years) were 
tested at the Australian Army Malaria 
Institute (Brisbane, Queensland, Aus-
tralia) for IgG antibodies against den-
gue virus. Thirteen participants were 
excluded from the original sample 
of 807 because of insufficient serum. 
Samples were screened by using the 
PanBio Dengue IgG Indirect ELISA 
Kits (Inverness Medical Innovations, 
Brisbane, Queensland, Australia) fol-
lowing the manufacturer’s recom-
mendations and protocols. PanBio 
Dengue IgG Indirect ELISA Kits can 
detect antibodies to all 4 dengue virus 
serotypes with a sensitivity of 99.2% 
and a specificity of 96.2% (5). How-
ever, these kits cannot identify the 
specific dengue serotypes responsible 
for infections. Results were calculated 
as counts and proportions of PanBio 
Units (PBU) and allocated a dengue 
IgG status accordingly: <9.0 PBU was 
a negative result, 9.0–11.0 PBU was 
an equivocal result, and >11.0 PBU 
was a positive result.
Serum samples from 759 
(95.6%, 95% CI 93.9%–96.8%) of 
794 study participants had IgG anti-
bodies against dengue virus (Table). 
Seroprevalence for men and women 
was comparable and did not differ 
from overall results. As expected, the 
seropositivity rate was lower among 
persons 18–25 years of age (89.1%, 
95% CI 84.0%–92.6%) because of 
less time exposed to dengue viruses, 
and the seropositivity rate was higher 
among persons 26–40 years of age 
(99.5%, 95% CI 97.5%–99.9%) than 
for the overall study population. De-
spite this study being limited by con-
venience sampling on the Manu’a 
Islands, it demonstrates almost uni-
versal exposure of sampled adults in 
American Samoa to dengue viruses.
In the absence of a vaccine, 
timely and accurate dengue surveil-
lance and consequent public health 
response is imperative. Current den-
gue surveillance in American Samoa 
is passive and relies on clinicians 
reporting suspected cases to public 
health authorities. Passive surveil-
lance systems are typically insensi-
tive, and barriers to treatment seeking 
by residents (distance to health care 
facility, financial costs, and encour-
agement from health authorities to 
stay at home unless symptoms are se-
vere) further reduces their efficiency 
(6). Moreover, passive surveillance 
systems do not capture asymptomatic 
infections, which contribute to dis-
ease transmission in the community 
during the viremic stage of illness. 
Development of an active surveil-
lance system incorporating geograph-
ic information systems would enable 
health authorities to better monitor 
distribution and intensity of acute in-
fections, identify high-risk areas, and 
target dengue control activities (7).
These preliminary findings 
should be evaluated by additional 
study. Further research into dengue 
seroprevalence in American Samoa 
should involve identifying dominant 
and circulating virus serotypes, study-
ing vector population dynamics, in-
vestigating dengue exposure among 
children, exploring environmental risk 
factors, and integrating these data into 
active geographically enhanced sur-
veillance systems. In addition, we sug-
gest implementing a sustainable vec-
tor control program similar to those 
undertaken in Vietnam to limit dengue 
transmission and reduce associated ill-
ness in American Samoa (8).
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Table.	Prevalence	of	IgG	against	dengue	virus	among	794	adults,	American	Samoa,	
2010* 
Characteristic No.	positive/no.	tested %	Positive	(95%	CI) 
Dengue	IgG	status   
 Negative,	PBU	<9.0 29/794 3.6	(2.6–5.2) 
 Equivocal,	PBU	9.0–11.0 6/794 0.8	(0.35–1.6) 
 Positive,	PBU	>11.0 759/794 95.6	(93.9–96.8) 
Sex   
 M 402/418 96.2	(93.9–97.6) 
 F 357/376 94.9	(92.2–96.7) 
Age,	y   
 18–25 179/201 89.1	(84.0–92.6) 
 26–40 216/217 99.5	(97.5–99.9) 
 41–53 182/187 97.3	(93.9–98.8) 
 54–87 182/189 96.3	(92.6–98.2) 
Total NA NA 
*PBU,	PanBio	units;	NA,	not	applicable. 
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Delayed Diagnosis 
of Dirofilariasis and 
Complex Ocular 
Surgery, Russia
To the Editor: Dirofilaria repens 
is a vector-borne, zoonotic, filarial 
nematode that infects dogs, cats, and 
humans. In humans, D. repens worms 
cause subcutaneous dirofilariasis, char-
acterized by the development of benign 
subcutaneous nodules that mimic skin 
carcinomas (1), and ocular dirofilaria-
sis in orbital, eyelid, conjunctival, ret-
roocular, and intraocular locations (2). 
Intraocular and retroocular dirofila-
riasis causes considerable damage and 
discomfort in patients from the pres-
ence of the worms and from their surgi-
cal removal (3). Here, we report a ret-
roocular D. repens nematode infection 
in a patient in Russia that illustrates 
the difficulties in clinical management 
and the inherent risks of surgical proce-
dures to remove the worms.
A 20-year-old woman living in 
Rostov-na-Donu in southwestern Rus-
sia who had never traveled outside the 
city sought ophthalmologic consul-
tation for pain and skin redness and 
swelling in the inner corner of the 
upper left eyelid. Swelling migrated 
successively to the temporal area, the 
lower eyelid, and the inner corner of 
the lower eyelid. The patient had no 
other ocular signs or symptoms, and 
her general condition was otherwise 
good. Results of ophthalmologic ex-
amination and routine laboratory tests 
were within normal limits. Four days 
of treatment with cefotaxime resulted 
in the remission of signs and symp-
toms. Approximately 2 months later, 
swelling in the inner corner of the 
upper eyelid appeared again, affect-
ing the whole upper eyelid, without 
itching or tenderness. Allergies were 
diagnosed; cetirizine was adminis-
tered for 4 days, and the signs remit-
ted at the third day of treatment. One 
month later, marked upper left eyelid 
swelling occurred, resulting in ptosis. 
Cetirizine was prescribed again; ede-
ma subsided after 4 days of treatment 
but relapsed in the following 3–4 days. 
At least 4 subsequent relapses oc-
curred; thus, a computed tomographic 
scan of the paranasal sinuses and or-
bits was performed, 4 months after 
signs and symptoms began (Figure, 
panel A). The scan detected a soft tis-
sue structure, 12 × 13 × 14 mm, be-
hind the left eyeball, adjacent to and 
medially dislodging the optic nerve. 
No other abnormalities were found 
in the visible area of the brain and 
sinuses. Magnetic resonance imag-
ing (MRI) performed 1 month later 
(Figure, panel B) corroborated the 
presence of a cyst-like structure with 
an irregular, rounded shape and clear, 
smooth borders closely adhered to the 
eyeball and optic nerve. T2-weighted 
images showed that the lesion had a 
high-density core but the surrounding 
tissue was low density. Adjacent to 
the lesion, the retrobulbar tissue was 
slightly swollen, the optic nerve was 
displaced medially and downward, 
and the adjacent upper muscle was 
displaced medially and upward. The 
diagnosis was evidence of a retroocu-
lar cystic lesion in the left orbit with a 
well-defined capsule and high-density 
but heterogeneous core structure. 
High-resolution ultrasound ex-
amination (Figure, panel C) revealed 
a well-defined, 3-mm, cyst-like wall 
containing fluid and dense, coiled-
twisted linear internal structures that 
appeared to be actively moving (Vid-
eo 1, Appendix, wwwnc.cdc.gov/EID/
article/19/2/12-1388-V1.htm). Color 
Doppler examination (Figure, panel 
D; Video 2, Appendix, wwwnc.cdc.
gov/EID/article/19/2/12-1388-V2.
htm) revealed blood vessels in the 
wall but not inside the cystic structure. 
These additional examinations led to 
a diagnosis of a retroocular parasitic 
cyst in the left orbit, most likely a Di-
rofilaria spp. parasite. The parasitic 
cystic nodule was removed during 
a transpalpebral orbitotomy. A live, 
adult roundworm, 87 × 0.6 mm, was 
